Loading organizations...
§ Private Profile · Urmonderbaan 20H, 6167 RD Geleen, the Netherlands
Reverdia, a JV powered by DSM and Roquette is a company.
Key people at Reverdia, a JV powered by DSM and Roquette.
Reverdia develops and commercializes Biosuccinium, a sustainable succinic acid that serves as a non-fossil feedstock-derived chemical building block. The company employs an advanced low-pH yeast technology for fermentative production, enabling a bio-based alternative for various industrial applications. This innovative approach allows industries to significantly reduce their ecological footprint by integrating more sustainable materials into their supply chains.
The joint venture Reverdia was established in June 2010 by Royal DSM N.V., a global leader in life and material sciences, and Roquette Frères, a prominent starch and starch-derivatives company. This partnership emerged from a shared understanding that the chemical industry required high-quality, renewable alternatives to fossil-based materials. Their collaborative efforts, initiated with technology development in early 2008, led to the operation of a dedicated commercial-scale plant in Cassano Spinola, Italy, by December 2012.
Reverdia primarily serves customers within the chemical industry seeking to produce more sustainable products for diverse markets, including packaging, footwear, and specialty polymers. The company’s vision centers on leading the global market for sustainable succinic acid, thereby empowering its clients to enhance environmental performance. Through the broad adoption of plant-based resources, Reverdia aims to contribute to a greener, more sustainable future for chemical manufacturing.
Reverdia was a joint venture between DSM and Roquette focused on producing and commercializing Biosuccinium™, a bio-based succinic acid derived from renewable resources. The company built a commercial-scale plant in Cassano Spinola, Italy, operational since 2012 with a capacity of 10,000 tonnes per year, using low-pH yeast technology to create a sustainable alternative to petroleum-based succinic acid.[1][3][4] It served industries like polyurethanes, automotive, textiles, coatings, resins, and biodegradable plastics (e.g., PBS), solving the problem of reducing environmental impact by offering a high-purity, low-impurity product with a favorable cradle-to-gate life cycle analysis compared to petro-based alternatives.[2][3][6] Reverdia demonstrated early growth by launching production, entering the market, and expanding to licensing in 2014, but was dissolved in April 2019, with operations transferred to Roquette under a DSM license.[2][3][4]
Reverdia emerged from a June 2010 joint venture agreement between Royal DSM N.V., a Dutch life sciences and materials sciences leader, and Roquette Frères, a French starch and derivatives specialist.[1][4][5] The idea stemmed from DSM's development of Biosuccinium™ technology, aiming to commercialize bio-succinic acid at scale using fermentation from renewable feedstocks.[3][4] Key milestones included regulatory approval and official launch in 2011, announcement of the Cassano plant construction in May 2011 (Europe's largest at the time), and operations starting in December 2012.[1][4][8] Early traction came from proving the technology's viability beyond startup phase, with market entry under the Biosuccinium™ brand.[2][3]
Reverdia rode the early 2010s wave of bio-based chemicals, addressing rising demand for renewable alternatives amid fossil fuel dependency and sustainability regulations.[1][3][6] Its timing capitalized on biotechnology advances in fermentation, proving commercial viability when competitors like PTT Global Chemical and BASF were scaling similar plants around 2013.[9] Market forces favoring it included growth in bio-economy sectors (e.g., bioplastics, green materials) driven by LCA benefits and certifications like USDA biobased.[6][7] By validating low-pH yeast tech, Reverdia influenced the ecosystem, paving the way for post-dissolution continuity under Roquette and inspiring industry shifts toward drop-in bio-monomers for existing supply chains.[2][3][6]
Post-2019 dissolution, Biosuccinium™ thrives under Roquette's operations with DSM as exclusive licensor, integrated into global sales for sustained growth in sustainable materials.[2][3][6] Upcoming trends like circular economy mandates, biodegradable plastics demand, and EU Green Deal policies will amplify its role, potentially expanding via Technip Energies' recent tech acquisition signaling broader licensing.[9] Reverdia's legacy as a bio-succinic pioneer endures, powering DSM and Roquette's shift to market-leading technologies in a maturing bio-based economy.[3]
Key people at Reverdia, a JV powered by DSM and Roquette.
